21 - 30 out of 136Page size: 10
  1. 2022

  2. A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)

    Stroes, C. I., Schokker, S., Khurshed, M., van der Woude, S. O., Mathôt, R. A. A., Slingerland, M., de Vos-Geelen, J., Zucchetti, M., Matteo, C., van Dijk, E., Ylstra, B., Thijssen, V., Derks, S., Godefa, T., Dijksterhuis, W., Breimer, G. E., van Delden, O. M., Verhoeven, R. H. A., Meijer, S. L., Bijlsma, M. F., & 1 othersvan Laarhoven, H. W. M., 2022, In: Therapeutic advances in medical oncology. 14

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2021

  4. Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma

    le Large, T. Y. S., Bijlsma, M. F., el Hassouni, B., Mantini, G., Lagerweij, T., Henneman, A. A., Funel, N., Kok, B., Pham, T. V., de Haas, R., Morelli, L., Knol, J. C., Piersma, S. R., Kazemier, G., van Laarhoven, H. W. M., Giovannetti, E. & Jimenez, C. R., 1 Dec 2021, In: Journal of experimental & clinical cancer research. 40, 1, 91.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk

    Peduzzi, G., Gentiluomo, M., Tavano, F., Arcidiacono, P. G., Ermini, S., Vodicka, P., Boggi, U., Cavestro, G. M., Capurso, G., Morelli, L., Milanetto, A. C., Pezzilli, R., Lawlor, R. T., Carrara, S., Lovecek, M., Souček, P., Guo, F., Hackert, T., Uzunoğlu, F. G., Gazouli, M., & 48 othersPárniczky, A., Kupcinskas, J., Bijlsma, M. F., Bueno-de-Mesquita, B., Vermeulen, R., van Eijck, C. H. J., Jamroziak, K., Talar-Wojnarowska, R., Greenhalf, W., Gioffreda, D., Petrone, M. C., Landi, S., Archibugi, L., Puzzono, M., Funel, N., Sperti, C., Piredda, M. L., Mohelnikova-Duchonova, B., Lu, Y., Hlaváč, V., Gao, X., Schneider, M., Izbicki, J. R., Theodoropoulos, G., Bunduc, S., Kreivenaite, E., Busch, O. R., Małecka-Panas, E., Costello, E., Perri, F., Testoni, S. G. G., Vanella, G., Pasquali, C., Oliverius, M., Brenner, H., Loos, M., Götz, M., Georgiou, K., Erőss, B., Maiello, E., Szentesi, A., Bazzocchi, F., Basso, D., Neoptolemos, J. P., Hegyi, P., Kiudelis, V., Canzian, F. & Campa, D., Dec 2021, In: Cancer epidemiology, biomarkers & prevention. 30, 12, p. 2342-2345 4 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer

    Dutch Pancreatic Cancer Group, Dec 2021, In: HPB. 23, 12, p. 1886-1896 11 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Continuous clonal labeling reveals uniform progenitor potential in the adult exocrine pancreas

    Lodestijn, S. C., van den Bosch, T., Nijman, L. E., Moreno, L. F., Schlingemann, S., Sheraton, V. M., van Neerven, S. M., Koning, J. J., Vieira Braga, F. A., Paauw, N. J., Lecca, M. C., Lenos, K. J., Morrissey, E., Miedema, D. M., Winton, D. J., Bijlsma, M. F. & Vermeulen, L., 4 Nov 2021, In: Cell stem cell. 28, 11, p. 2009-2019.e4

    Research output: Contribution to journal › Article › Academic › peer-review

  8. The role of transforming growth factor β in upper gastrointestinal cancers: A systematic review

    Veen, L. M., Skrabanja, T. L. P., Derks, S., de Gruijl, T. D., Bijlsma, M. F. & van Laarhoven, H. W. M., 1 Nov 2021, In: Cancer treatment reviews. 100, 102285.

    Research output: Contribution to journal › Review article › Academic › peer-review

  9. Protease-activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinoma

    Tekin, C., Scicluna, B. P., Lodestijn, S. C., Shi, K., Bijlsma, M. F. & Spek, C. A., Nov 2021, In: Molecular oncology. 15, 11, p. 3091-3108 18 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer

    Lodestijn, S. C., Miedema, D. M., Lenos, K. J., Nijman, L. E., Belt, S. C., el Makrini, K., Lecca, M. C., Waasdorp, C., van den Bosch, T., Bijlsma, M. F. & Vermeulen, L., 19 Oct 2021, In: Cell reports. 37, 3, 109852.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth

    Manoukian, P., Bijlsma, M. & van Laarhoven, H., 27 Sept 2021, In: Frontiers in cell and developmental biology. 9, 743907.

    Research output: Contribution to journal › Review article › Academic › peer-review

  12. Erratum: Stromal-derived interleukin 6 drives epithelialto- mesenchymal transition and therapy resistance in esophageal adenocarcinoma (Proc. Natl. Acad. Sci. U.S.A. (2019) 116 (2237-2242) DOI: 10.1073/pnas.1820459116)

    Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Hooijer, G. K. J., Meijer, S. L., Krishnadath, K. K., Punt, C. J. A., van Berge Henegouwen, M. I., Gisbertz, S. S., van Delden, O. M., Hulshof, M. C. C. M., Medema, J. P., van Laarhoven, H. W. M. & Bijlsma, M. F., 14 Sept 2021, In: Proceedings of the National Academy of Sciences of the United States of America. 118, 37, e2113728118.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 41996